Inappropriate antibiotic administration in the setting of Charcot arthropathy: A case series and literature review.


Journal

Primary care diabetes
ISSN: 1878-0210
Titre abrégé: Prim Care Diabetes
Pays: England
ID NLM: 101463825

Informations de publication

Date de publication:
02 2022
Historique:
received: 22 06 2021
revised: 15 11 2021
accepted: 28 11 2021
pubmed: 12 12 2021
medline: 22 3 2022
entrez: 11 12 2021
Statut: ppublish

Résumé

Differentiating Charcot neuropathic osteoarthropathy (CN) from infection is challenging. The diagnosis of CN is often missed or delayed, resulting in inappropriate and delayed treatment. We hypothesized that the misdiagnosis of CN results in inappropriate antibiotic prescriptions and explore the sequelae of unnecessary antibiotic use. A retrospective review of patient electronic medical records from January 2010 to December 2017 was conducted for those diagnosed with CN after being referred to an orthopaedic foot and ankle specialist. Our review showed 58 of 103 (56%) patients received antibiotics on the date, or within the next 7 days, of referral to foot and ankle orthopaedic specialist. The antibiotic of choice given on referral were as follows: Sulfamethoxazole/Trimethoprim 18 of 58 (31%), doxycycline 13 of 58 (22%), clindamycin 13 of 58 (22%), cephalexin 9 of 58 (16%), minocycline 5 of 58 (9%). Missed diagnoses for CN are common and result in complications stemming from inappropriate treatment, delays in appropriate therapy, and may accelerate antibiotic resistance. Misdiagnosis of CN contributes to the inappropriate use of prescription antibiotics.

Identifiants

pubmed: 34893452
pii: S1751-9918(21)00216-3
doi: 10.1016/j.pcd.2021.11.009
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

202-206

Informations de copyright

Copyright © 2021 Primary Care Diabetes Europe. All rights reserved.

Auteurs

Kiya Shazadeh Safavi (K)

Department of Orthopaedic Surgery and Rehabilitation, University of Texas Medical Branch, Galveston, TX 77555, United States. Electronic address: kiyasafavimd@gmail.com.

Cory Janney (C)

Department of Orthopaedic Surgery and Rehabilitation, University of Texas Medical Branch, Galveston, TX 77555, United States; Naval Medical Center San Diego, San Diego, CA 91941, United States.

Pejma Shazadeh Safavi (P)

Department of Medicine, University of Toledo, Toledo, OH 43614, United States.

Daniel Kunzler (D)

Department of Orthopaedic Surgery Baylor Scott & White, Temple, TX 76502, United States.

Daniel Jupiter (D)

Department of Orthopaedic Surgery and Rehabilitation, University of Texas Medical Branch, Galveston, TX 77555, United States.

Vinod Panchbhavi (V)

Department of Orthopaedic Surgery and Rehabilitation, University of Texas Medical Branch, Galveston, TX 77555, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH